1. Bartells, H., Brener, K., Brittinger, G., Burger, A., Druhmke, E., Gunzer, U., Konig, E., Stacher, A., Theml, H., Waldner, R.: Clinical significance of the Kiehl classification of the Non- Hodgkin’s lymphomas. Abstract S-19–5, p. 60. In: Abstracts of the 16th International Congress of Haematol., Kyoto, 1976
2. Belpomme, D., Lelarge, N., Mathé, G., Davies, A. J. S.: Etiological clinical and prognostic significance of the T-B immunological classification of primary acute lymphoid leukemias and non- Hodgkin’s lymphomas, pp. 33–45. In: “Immunological Diagnosis of Leukemias and Lymphomas” (Thierfelder, S., Rodt, H., Thiel, E. eds.) Heidelberg, New York: Springer, 1977
3. Belpomme, D., Caillou, B., Lelarge, N., Botto, I., Gerard-Marchant, A., Rappaport, H., Davies, A. J. S., Mathé, G.: Prognostic value and clinical significance of the T-B-“null” immunological classification of non-Hodgkin’s lymphomas: its correlation with other classifications. In: “Lymphoid Neoplasias II” (RRCR) (MATHÉ, G., Seligmann, M., Tubiana, M. eds.), pp. 28–40. Berlin- Heidelberg-New York: Springer, 1978
4. Blum, R. H., Carter, S. K., Agre, K.: A clinical review of bleomycin, an antineoplastic agent. Cancer, 31, 309 (1973)
5. Carter, S. K.: An overview of the status of the nitrosoureas in other tumours. Cancer Chemother. Rep., Part 3, 4, 35 (1973)